IL-32 is typically highly expressed in inflammatory diseases and various malignant tumors, inducing the release of cytokines and playing a crucial role in the formation of the inflammatory microenvironment, thereby promoting the growth, migration, and invasion of tumor cells16–18. This evidence concerns the gene IL32 and cancer.